Atorvastatin
Generic Name: Atorvastatin
Uses & Medical Indications
Lower cholesterol
Hyperlipidemia, cardiovascular risk reduction
Work Mechanism & Pharmacology
Patient Overview of Work Mechanism
Atorvastatin shuts down the liver enzyme that manufactures bad LDL cholesterol, prompting the liver to clear existing cholesterol out of the bloodstream, preventing arterial plaques and cardiovascular events.
Clinical Mechanism of Action (MoA)
Potent, competitive, and selective inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in cholesterol biosynthesis. Depletion of intracellular cholesterol upregulates hepatic low-density lipoprotein (LDL) receptors, promoting hepatic clearance of atherogenic LDL and VLDL particles from circulation.
Dosage & Administration Guidelines
10-80 mg daily
10-20 mg daily (over 10 yrs)
Start at lower end of range
80 mg/day
No adjustment needed
Contraindicated in active liver disease
Side Effects & Safety Warnings
Muscle pain, diarrhea
Rhabdomyolysis, hepatotoxicity
Active liver disease, pregnancy
Risk of myopathy
Interactions (Drugs, Food & Alcohol)
Cyclosporine, Clarithromycin
Grapefruit juice
Use with caution
Identified Clinical Drug Interactions for Atorvastatin:
Dramatically increased plasma concentrations of Atorvastatin, multiplying risk of severe rhabdomyolysis.
Marked Elevation in Statin Levels & Acute Rhabdomyolysis
Elevated Atorvastatin Concentrations & Muscle Toxicity
Pregnancy & Breastfeeding Safety
Contraindicated
Contraindicated
Patient Counseling & Practical Advice
Report unexplained muscle pain
Skip if more than 12 hours late
Lipid panel
Frequently Asked Questions
When to Seek Urgent Medical Attention
Severe widespread muscle pain with fever and brown/cola-colored urine (Rhabdomyolysis).
Content for Atorvastatin was synthesized from standardized public health monographs, official pharmacopoeias, and health authorities:
- American Heart Association / ACC — Guideline on the Management of Blood Cholesterol
- European Society of Cardiology (ESC) — ESC/EAS Guidelines for the Management of Dyslipidaemias
The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.